The genetics of Alzheimer disease and the application of molecular tests

Genetic Testing

Volumn 3, Issue 1, 1999, Pages 37-45

  Tobin, Sara L ^a   Chun, Nicki ^b   Powell, Traci M ^a   McConnell, Laura M ^a  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRESENILIN 1;

ALLELE; ALZHEIMER DISEASE; DIAGNOSTIC VALUE; GENE MUTATION; HUMAN; PROTEIN EXPRESSION; REVIEW;

EID: 0033004041     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.1999.3.37     Document Type: Review

References (76)

1. AMERICAN COLLEGE OF MEDICAL GENETICS, AMERICAN SOCIETY OF HUMAN GENETICS, AND WORKING GROUP ON APOE AND ALZHEIMER DISEASE. (1995). Statement on use of apolipoprotein E testing for Alzheimer disease. J. Am. Med. Assn. 274, 1627-1629.
2. ATHENA DIAGNOSTICS (1999). New Athena Admark assays for greater certainty in AD diagnosis and prognosis. Alzheimer's Disease Diagnosis Service, product information.
3. BIRD, T.D. (1995). Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: A cautionary view [editorial]. Ann. Neurol. 38, 2-4.
4. BLACKER, D., HAINES, J.L., RODES, L., et al. (1997). ApoE-4 and age at onset of Alzheimer's disease: The NLMH Genetics Initiative. Neurology 48, 139-147.
5. BOISSIERE, F., FAUCHEUX, B., RUBERG, M., et al. (1997). Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease. Exp. Neurol. 145, 245-252.
6. BUTLER, R.N. (1994). ApoE: New risk factor for Alzheimer's [editorial]. Geriatrics 49, 10-11.
7. CAMPION, D., FLAMAN, J.M., BRICE, A., et al. (1995). Mutations of the presenilin I gene in families with early-onset Alzheimer's disease. Hum. Mol. Genet. 4, 2373-2377.
8. CAMPION, D., BRICE, A., HANNEQUIN, D., et al. (1996). No founder effect in three novel Alzheimer's disease families with APP 717 Val → Ile mutation. Clerget-darpoux. French Alzheimer's Disease Study Group. J. Med. Genet. 33, 661-664.
9. CHARTIER-HARLIN, M.C., CRAWFORD, F., and HOULDEN, H. (1991). Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 353, 844-846.
10. CHARTIER-HARLIN, M.C., PARFITT, M., LEGRAIN, S., et al. (1994). Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum. Mol. Genet. 3, 569-574.
11. COMBARROS, O., LENO, C., OTERINO, A., et al. (1998). Gender effect on apolipoprotein E epsilon4 allele-associated risk for sporadic Alzheimer's disease. Acta Neurol. Scand. 97, 68-71.
12. CORDER, E.H., SAUNDERS, A.M., STRITTMATTER, W.J., et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923.
13. CORDER, E.H., SAUNDERS, A.M., STRITTMATTER, W.J., et al. (1995). The apolipoprotein E E4 allele and sex-specific risk of Alzheimer's disease [letter]. J. Am. Med. Assn. 273, 373-374.
14. CROOK, R., VERKKONIEMI, A., and PEREZ-TUR, J. (1998). A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nature Med. 4, 452-455.
15. CRUTS, M., HENDRIKS, L., and VAN BROECKHOVEN, C. (1996). The presenilin genes: a new gene family involved in Alzheimer disease pathology. Hum. Mol. Genet. 5, 1449-1455.
16. DAVIS, R.E., MILLER, S., and HERRNSTADT, C. (1997). Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 94, 4526-4531.
17. DE LA MONTE, S.M., GHANBARI, K., FREY, W.H., et al. (1997). Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid. J. Clin. Invest. 100, 3093-3104.
18. DUARA, R., BARKER, W.W., LOPEZ-ALBEROLA, R., et al. (1996). Alzheimer's disease: interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset. Neurology 46, 1575-1579.
19. EDLAND, S.D., SILVERMAN, J.M., PESKIND, E.R., et al. (1996). Increased risk of dementia in mothers of Alzheimer's disease cases: evidence for maternal inheritance. Neurology 47, 254-256.
20. EMI, M., WU, L.L., ROBERTSON, M.A., et al. (1988). Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 3, 373-379.
21. FARRER, L.A., CUPPLES, L.A., HAINES, J.L., et al. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. J. Am. Med. Assn. 278, 1349-1356.
22. FIDANI, L., ROOKE, K., CHARTIER-HARLIN, M.C., et al. (1992). Screening for mutations in the open reading frame and promoter of the beta-amyloid precursor protein gene in familial Alzheimer's disease: identification of a further family with APP717 Val → Ile. Hum. Mol. Genet. 1, 165-168.
23. GLENNER, G.G., and WONG, C.W. (1984). Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
24. GOATE, A., CHARTIER-HARLIN, M.C., MULLAN, M., et al. (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706.
25. GREELY, H.T. (1999). Special problems in genetic testing for Alzheimer disease. Genet. Testing 3, 000-000.
26. HUTTON, M., and HARDY, J. (1997). The presenilins and Alzheimer's disease. Hum. Mol. Genet. 6, 1639-1646.
27. HUTTON, M., BUSFIELD, F., WRAGG, M., et al. (1996). Complete analysis of the presenilin 1 gene in early onset Alzheimer's disease. Neuroreport 7, 801-805.
28. HYMAN, B.T., GOMEZ-ISLA, T., REBECK, G.W., et al. (1996a). Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease. Ann. N.Y. Acad. Sci. 802, 1-5.
29. HYMAN, B.T., HEDLEY-WHYTE, E.T., REBECK, G.W., et al. (1996b). Apolipoprotein E epsilon4/4 in a neuropathologically normal very elderly individual [letter]. Arch. Neurol. 53, 215.
30. LENDON, C.L., ASHALL, F., and GOATE, A.M. (1997). Exploring the etiology of Alzheimer disease using molecular genetics. J. Am. Med. Assn. 227, 825-831.
31. LEVY-LAHAD, E., WASCO, W., POORKAJ, P., et al. (1995a). Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-977.
32. LEVY-LAHAD, E., WIJSMAN, E.M., NEMENS, E., et al. (1995b). A familial Alzheimer's disease locus on chromosome 1. Science 269, 970-973.
33. LEVY-LAHAD, E., and BIRD, T.D. (1996). Genetic factors in Alzheimer's disease: A review of recent advances. Ann. Neurol. 40, 829-840.
34. LOCKE, P.A., CONNEALLY, P.M., TANZI, R.E., et al. (1995). Apolipoprotein E4 allele and Alzheimer disease: examination of allelic association and effect on age at onset in both early-and late-onset cases. Genet. Epidemiol. 12, 83-92.
35. MANN, D.M. (1988). The pathological association between Down syndrome and Alzheimer disease. Mech. Ageing Dev. 43, 99-136.
36. McCONNELL, L.M. (1999). Understanding genetic testing for Alzheimer disease: medical and epidemiological background. Genet. Testing 3, 21-27.
37. McCONNELL, L.M., KOENIG, B.K., GREELY, H.T., et al. (1999a). Genetic testing and Alzheimer disease: Recommendations of the Stanford Program in Genomics, Ethics, and Society. Genet. Testing 3, 3-12.
38. McCONNELL, L.M., SANDERS, G., and OWENS, D.K. (1999b). Evaluation of genetic tests: APOE genotyping for the diagnosis of Alzheimer disease. Genet. Testing 3, 47-53.
39. McLEAN, J.W., ELSHOURBAGY, N.A., CHANG, D.J., et al. (1984). Human apolipoprotein E mRNA: cDNA cloning and nucleotide sequencing of a new variant. J. Biol. Chem. 259, 6498-6504.
40. MEDICAL AND SCIENTIFIC ADVISORY COMMITTEE, AND ALZHEIMER'S DISEASE INTERNATIONAL. (1995). Consensus statement on predictive testing for Alzheimer disease. Alzheimer Dis. Assoc. Disord. 9, 182-187.
41. MUCKLE, T.J., and ROY, J.R. (1985). High-density lipoprotein cholesterol in differential diagnosis of senile dementia. Lancet. 1, 1191-1993.
42. MURAMATSU, T., MATSUSHITA, S., ARAI, H., et al: (1996). Alpha 1-antichymotrypsin gene polymorphism and risk for Alzheimer's disease. J. Neural Transm. 103, 1205-1210.
43. NATIONAL INSTITUTE ON AGING, AND ALZHEIMER'S ASSOCIATION WORKING GROUP. (1996). Apolipoprotein E genotyping in Alzheimer's disease. Lancet 347, 1091-1095.
44. NICOLL, J.A., ROBERTS, G.W., and GRAHAM, D.I. (1996). Amyloid beta-protein, APOE genotype and head injury. Ann. N.Y. Acad. Sci. 777, 271-275.
45. O'MEARA, E.S., KUKULL, W.A., SHEPPARD, L., et al. (1997). Head injury and risk of Alzheimer's disease by apolipoprotein E genotype. Am. J. Epidemiol. 146, 373-384.
46. PAYAMI, H., ZAREPARSI, S., MONTEE, K.R., et al. (1996). Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am. J. Hum. Genet. 58, 803-811.
47. PAYAMI, H., SCHELLENBERG, G.D., ZAREPARSI, S., et al. (1997). Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease. Neurology 49, 512-518.
48. PERICAK-VANCE, M.A., BEBOUT, J.L., GASKELL, P.C., et al. (1991). Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am. J. Hum. Genet. 48, 1034-1050.
49. PERICAK-VANCE, M.A., BASS, M.P., and YAMAOKA, L.H. (1997). Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. J. Am. Med. Assn. 278, 1237-1241.
50. PLASSMAN, B.L., and BREITNER, J.C. (1996). Recent advances in the genetics of Alzheimer's disease and vascular dementia with an emphasis on gene-environment interactions. J. Am. Geriatr. Soc. 44, 1242-1250.
51. POST, S.G. (1996). On not jumping the gun: ethical aspects of APOE gene testing for Alzheimer's disease. Ann. N.Y. Acad. Sci. 802, 111-119.
52. POST, S.G., WHITEHOUSE, P.J., BINSTOCK, R.H., et al. (1997). The clinical introduction of genetic testing for Alzheimer disease: An ethical perspective. J. Am. Med. Assn. 227, 832-836.
53. RALL, S.C., and MAHLEY, R.W. (1992). The role of apolipoprotein E genetic variants in lipoprotein disorders. J. Intern. Med. 231, 653-659.
54. RALL, S.C., WEISGRABER, K.H., INNERARITY, T.L., and MAHLEY, R.W. (1982). Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects. Proc. Natl. Acad. Sci. USA. 79, 4696-4700.
55. RELKIN, N.R., KWON, Y.J., TSAI, J., and GANDY, S. (1996). The National Institute on Aging/Alzheimer's Association recommendations on the application of apolipoprotein E genotyping to Alzheimer's disease. Ann. N.Y. Acad. Sci. 802, 149-171.
56. RIGGS, J.E. (1996). The "protective" influence of cigarette smoking on Alzheimer's and Parkinson's diseases. Quagmire or opportunity for neuroepidemiology? Neurol. Clin. 14, 353-358.
57. ROGAEV, E.I., SHERRINGTON, R., ROGAEVA, E.A., et al. (1995). Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778.
58. ROSES, A.D. (1995). Apolipoprotein E genotyping in the differential diagnosis, but prediction, of Alzheimer's disease. Ann. Neurol. 38, 6-14.
59. ROSES, A.D. (1996). Apolipoprotein E and Alzheimer's disease: A rapidly expanding field with medical and epidemiological consequences. Ann. N.Y. Acad. Sci. 802, 50-57.
60. SAUNDERS, A.M., STRITTMATTER, W.J., SCHMECHEL, D., et al. (1993). Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472.
61. SAUNDERS, A.M., HULETTE, C., WELSH-BOHMER, K.A., et al. (1996). Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet 348, 90-93.
62. SCHELLENBERG, G.D., BIRD, T.D., and WIJSMAN, E.M. (1992). Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258, 668-671.
63. SELKOE, D.J. (1996). Amyloid beta-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271, 18295-18298.
64. SESHADRI, A., DRACHMAN, D.A., and LIPPA, C.F. (1995). Apolipoprotein E e4 allele and the lifetime risk of Alzheimer's disease. Arch. Neurol. 52, 1074-1079.
65. SHERRINGTON, R., ROGAEV, E.I., LIANG, Y., et al. (1995). Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
66. SHERRINGTON, R., FORELICH, S., SORBI, S., et al. (1996). Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum. Mol. Genet. 5, 985-988.
67. ST CLAIR, D., RENNIE, M., SLORACH, E., et al. (1995). Apolipoprotein E epsilon 4 allele is a risk factor for familial and sporadic presenile Alzheimer's disease in both homozygote and heterozygote carriers. J. Med. Genet. 32, 642-644.
68. STEPHENSON, J. (1997). Researchers find evidence of a new gene for late-onset Alzheimer disease. J. Am. Med. Assn. 227, 775.
69. STRITTMATTER, W.J., SAUNDERS, A.M., SCHMECHEL, D., et al. (1993). Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 1977-1981.
70. TANG, M.X., MAESTRE, G., TSAI, W.Y., et al. (1996a). Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer's disease. Ann. N.Y. Acad. Sci. 802, 6-15.
71. TANG, M.-X., MAESTRE, G., TSAI, W.-Y., et al. (1996b). Relative risk of Alzheimer disease and age-at-onset distribution, based on APOE genotypes among elderly African-Americans, Caucasians, and Hispanics in New York City. Am. J. Hum. Genet. 58, 574-584.
72. TANG, M.-X., STERN, Y., MARDER, K., et al. (1998). The APOE-e4 allele and the risk of Alzheimer disease among African Americans, Whites, and Hispanics. J. Am. Med. Assn. 279, 751-755.
73. THINAKARAN, G., BORCHELT, D.R., LEE, M.K., et al. (1996). Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17, 181-190.
74. WALDEN, C.C., and HEGELE, R.A. (1994). Apolipoprotein E in hyperlipidemia. Ann. Intern. Med. 120, 1026-1036.
75. WEISGRABER, K.H., RALL, S.C., and MAHLEY, R.W. (1981). Human E apoprotein heterogeneity: Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J. Biol. Chem. 256, 9077-9083.
76. YANKNER, B.A. (1998). Monster plaques: What they tell us about Alzheimer's disease. Nature Med. 4, 394-395.